AI
Alphabet Inc Portfolio holdings
AUM
$2.14B
This Quarter Return
+51.28%
1 Year Return
+56.95%
3 Year Return
+189.16%
5 Year Return
+193.61%
10 Year Return
+303.91%
AUM
$2.14B
AUM Growth
+$2.14B
(+35%)
Cap. Flow
-$84.6M
Cap. Flow
% of AUM
-3.96%
Top 10 Holdings %
Top 10 Hldgs %
89.61%
Holding
40
New
–
Increased
–
Reduced
2
Closed
4
Top Buys
No buys this quarter
Top Sells
| 1 |
Lyell Immunopharma
LYEL
|
$49.3M |
| 2 |
CrowdStrike
CRWD
|
$26.2M |
| 3 |
DM
Desktop Metal, Inc.
DM
|
$5.42M |
| 4 |
VERV
Verve Therapeutics
VERV
|
$2.03M |
| 5 |
KRON
Kronos Bio
KRON
|
$1.19M |
Sector Composition
| 1 | Technology | 55.72% |
| 2 | Healthcare | 35.16% |
| 3 | Industrials | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
TScan Therapeutics
TCRX
$102M
| $1.56M | 0.07% |
1,077,080
| – | – |
|
27
Taysha Gene Therapies
TSHA
$797M
| $1.48M | 0.07% |
640,882
| – | – |
|
|
BRNS
28
Barinthus Biotherapeutics
BRNS
$45.6M
| $1.41M | 0.07% |
1,513,644
| – | – |
|
29
Exact Sciences
EXAS
$8.98B
| $1.23M | 0.06% |
23,205
| – | – |
|
30
Fractyl Health
GUTS
$68.8M
| $1.07M | 0.05% |
662,584
| – | – |
|
31
Hyperfine
HYPR
$97.4M
| $647K | 0.03% |
898,720
| – | – |
|
32
Tenaya Therapeutics
TNYA
$184M
| $559K | 0.03% |
915,705
| – | – |
|
33
Quince Therapeutics
QNCX
$85.9M
| $312K | 0.01% |
189,122
| – | – |
|
34
Alector
ALEC
$238M
| $246K | 0.01% |
175,866
| – | – |
|
35
Fulcrum Therapeutics
FULC
$351M
| $98.1K | ﹤0.01% |
14,262
| – | – |
|
36
Repligen
RGEN
$6.88B
| $47.6K | ﹤0.01% |
383
| – | – |
|
|
37
CrowdStrike
CRWD
$106B
| – | – |
-74,230
| Closed | -$26.2M |
|
|
KRON
38
DELISTED
Kronos Bio
KRON
| – | – |
-1,438,232
| Closed | -$1.19M |
|
39
Rani Therapeutics
RANI
$24.4M
| – | – |
-448,492
| Closed | -$565K |
|
|
DM
40
DELISTED
Desktop Metal, Inc.
DM
| – | – |
-1,104,871
| Closed | -$5.42M |
|